报价延迟最少15分钟:2026/02/09 21:35 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.78 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-7.52/-1.46
|
|
企业价值
1.57B
|
| 资产负债 |
|
每股账面净值
-0.13
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
